

| Package | Price per Dose | Price | |
|---|---|---|---|
| 360 pills | £0.85 | £407.48 £305.61 Free shipping | |
| 180 pills | £0.90 | £214.07 £160.55 Free shipping | |
| 120 pills | £0.91 | £146.15 £109.61 | |
| 90 pills | £0.95 | £113.67 £85.25 | |
| 60 pills | £1.00 | £79.71 £59.78 | |
| 30 pills | £1.14 | £45.75 £34.32 | |
| 360 pills | £1.27 | £612.70 £459.53 Free shipping | |
| 240 pills | £1.30 | £414.86 £311.14 Free shipping | |
| 180 pills | £1.31 | £314.46 £235.85 Free shipping | |
| 120 pills | £1.33 | £212.59 £159.44 Free shipping | |
| 90 pills | £1.36 | £163.87 £122.90 | |
| 60 pills | £1.38 | £112.19 £84.14 | |
| 30 pills | £1.42 | £57.57 £43.17 | |
| 240 pills | £1.96 | £627.46 £470.60 Free shipping | |
| 180 pills | £1.98 | £475.39 £356.54 Free shipping | |
| 120 pills | £2.00 | £320.37 £240.28 Free shipping | |
| 90 pills | £2.03 | £243.59 £182.70 Free shipping | |
| 60 pills | £2.07 | £165.34 £124.01 | |
| 30 pills | £2.21 | £88.57 £66.43 | |
| 180 pills | £2.62 | £628.94 £471.71 Free shipping | |
| 120 pills | £2.71 | £434.05 £325.54 Free shipping | |
| 90 pills | £2.74 | £327.75 £245.81 Free shipping | |
| 60 pills | £2.77 | £221.45 £166.09 Free shipping | |
| 30 pills | £2.88 | £115.15 £86.36 |
Disclaimer: This information is for patient education and should not replace professional medical advice. Seek personalised guidance from a pharmacist or doctor for decisions about treatment.
Paxil is a selective serotonin reuptake inhibitor (SSRI) that is used in the treatment of mood and anxiety disorders.
The SSRI class works by increasing the level of serotonin (a brain chemical involved in mood regulation) in the brain, which can help improve mood and reduce anxiety.
Paxil is prescribed in immediate-release and extended-release forms to suit different dosing regimens.
In the United Kingdom, Paxil may require a prescription from a healthcare professional depending on local regulations.
Its primary therapeutic purpose includes the treatment of major depressive disorder and several anxiety-related conditions, such as generalized anxiety disorder and panic disorder.
It is typically considered after failure or intolerance to other treatments, or when comorbid conditions influence the choice of antidepressant therapy.
Paxil is used to treat major depressive disorder and a spectrum of anxiety disorders; the choice between Paxil and other antidepressants depends on symptom profile, prior response, and tolerability.
Depressive disorders
Paxil may be prescribed for major depressive disorder where anxiety or sleep disturbance accompanies mood symptoms; effectiveness is recognized in clinical practice, with individual responses varying.
Anxiety disorders
Paxil has been used in generalized anxiety disorder, panic disorder, social anxiety disorder, and, in certain circumstances, obsessive-compulsive disorder; the decision to use Paxil depends on the overall symptom pattern and coexisting conditions.
Alternative options
In some patients, other SSRIs or different antidepressants may be preferred due to side effect profiles, drug interactions, or comorbidity considerations.
Check the official leaflet or consult a healthcare professional to confirm current indications and suitability for specific symptoms.
Paxil shares the core mechanism of serotonin reuptake inhibition with other SSRIs but differs in receptor selectivity and pharmacokinetic properties that influence effects and tolerability.
Onset and tolerability
As with SSRIs, symptom improvement may be gradual, often taking several weeks; Paxil is associated with characteristic side effects that may differ from other agents in this class.
Discontinuation and switching
Discontinuation symptoms may occur with abrupt cessation; gradual tapering and clinician-guided switching strategies are advised.
Pregnancy and lactation considerations
In pregnancy or breastfeeding, risk–benefit considerations are essential; Paxil is generally avoided in early pregnancy unless benefits clearly outweigh potential risks.
Cardiovascular considerations
A history of heart rhythm problems should be discussed with a clinician before use, as cardiovascular safety profiles differ among antidepressants.
| Name | Primary use | Typical onset | Key advantage |
|---|---|---|---|
| Paxil (paroxetine) | Depression and multiple anxiety disorders | Early benefit may appear within 1–2 weeks; full effect often over several weeks | Broad signal of efficacy in anxiety-related conditions for many patients |
| fluoxetine (Prozac) | Depression and certain anxiety disorders | Symptom improvement often evident within 2–3 weeks | Long half-life; easier to discontinue; activating effect can counter fatigue in some patients |
| sertraline (Zoloft) | Depression and anxiety disorders including OCD | Improvement typically seen within 2–4 weeks | Generally well tolerated; flexible dosing and diverse indications |
| citalopram (Celexa) | Depression and anxiety spectrum | Often 2–4 weeks for initial response | Widely used with predictable tolerability across many patients |
These comparisons provide a general framework; individual response varies, and decisions should align with clinical evaluation and patient preferences.
Choosing between agents depends on symptom profile, prior response, safety considerations, and potential interactions with other medications.
Generic paroxetine is available in many settings; brand Paxil may be preferred in some contexts, but availability varies by location and formulary.
Consultation with a pharmacist or prescriber is advised to interpret these considerations in the context of the individual’s medical history.
Paxil is taken orally, with or without food, as directed by a healthcare professional.
Extended-release formulations are designed for once-daily dosing and may have specific instructions regarding timing and missed doses.
Initial dosing and any changes should be guided by a clinician; adjustments are made based on response and tolerability.
Storage should follow the product leaflet, with attention to protecting tablets from moisture and heat.
If a dose is missed, instructions from a healthcare professional should be followed; do not double up doses without advice.
Approximately several weeks may be required to assess full response to Paxil; routine follow-up is advised to monitor mood, anxiety symptoms, and adverse effects.
Any new or worsening symptoms, including mood changes, thoughts of self-harm, or unusual behavior, should be reported promptly to a clinician.
Dose changes are generally gradual to minimise withdrawal or adverse effects; adhere to a clinician’s schedule for any titration.
Concomitant medications should be reviewed to assess interactions and adjust therapy as needed.
A healthcare professional can provide personalised advice regarding the duration of treatment and plans for stopping Paxil if required.
If a dose is missed, the recommended action should be taken according to local guidance or a clinician’s directive; do not take extra doses to catch up.
When travelling across time zones or altering daily routines, inform the prescriber to adjust dosing if necessary.
Even with a stable regimen, sudden changes in appetite, sleep, or energy may occur and should be discussed with a clinician.
Storage during travel should maintain stability; follow product-specific guidance on storage while away from home.
Do not stop Paxil abruptly without medical advice, as withdrawal symptoms can occur and may require a tapering plan.
Discontinuation of Paxil requires clinician guidance to minimise withdrawal risk and to prevent symptom relapse.
It is important to keep all appointments and report any adverse effects, particularly those that are concerning or persistent.
Alcohol consumption should be discussed with a clinician, as interactions can affect mood and sedation.
Activities requiring alertness, such as driving or operating machinery, should be approached with caution if dizziness or sedation occurs.
Long-term use requires periodic review to assess ongoing need and to monitor for side effects or interactions.
Common side effects may include nausea, dry mouth, sleep disturbance, and changes in appetite or energy; these often lessen with time.
Sexual dysfunction, sweating, and dizziness are reported by some patients; these experiences should be discussed with a clinician if persistent.
Less frequent effects can include changes in weight, tremor, or headaches; reporting persistent symptoms is advised.
Serious adverse effects are uncommon but require urgent medical evaluation; seek medical help if signs of severe allergic reaction, chest pain, severe mood changes, or confusion arise.
Individuals should seek medical help immediately if there are signs of serotonin syndrome, such as fever, agitation, confusion, or muscle rigidity.
Paxil is contraindicated in known hypersensitivity to paroxetine or any component of the formulation.
Concurrent use with irreversible monoamine oxidase inhibitors (MAOIs) is not advised; interactions can be dangerous.
Hepatic impairment, age-related considerations, and certain cardiovascular histories require careful evaluation by a clinician before starting therapy.
A clinician should be informed about all medicines and supplements to assess interaction risk and adjust therapy if needed.
In pregnancy, the potential risks and benefits must be weighed; Paxil may be avoided in the first trimester unless benefits exceed potential risks.
Breastfeeding considerations should be discussed with a clinician; paroxetine can pass into breast milk and may affect the infant.
In elderly patients or those with liver impairment, careful dosing and monitoring are essential due to altered metabolism and sensitivity to side effects.
SSRIs including Paxil can interact with other serotonergic drugs or MAOIs, potentially increasing the risk of serotonin-related adverse effects.
Non-steroidal anti-inflammatory drugs (NSAIDs) or anticoagulants may affect bleeding risk when used with SSRIs; caution and professional guidance are advised.
Gradual adjustments are often necessary when combining Paxil with other medicines; a clinician should review all current therapies.
Herbal supplements or alcohol can influence mood and safety when used with Paxil; disclosure to a clinician is recommended.
Knowledge of CYP enzyme interactions helps anticipate metabolism-related changes; some medicines may require dose adjustments or alternative therapies.
Patients should not start or stop other antidepressants abruptly; any change should be supervised by a healthcare professional.
Careful evaluation is required for use during pregnancy; a clinician will discuss potential risks to the fetus and the mother.
Breastfeeding considerations should be weighed against benefits; alternative feeding options may be discussed if required.
If pregnancy occurs or is planned, medical advice should be sought promptly to review the treatment plan.
In older adults, the risk of certain side effects may be higher; dosing and monitoring may differ from younger adults.
In liver impairment, metabolism can be slowed; clinician guidance is essential to determine suitability and dosing.
Impairment of concentration or dizziness can occur; activities requiring full alertness should be approached with caution initially.
The questions below cover common concerns about Paxil, its use, and how it compares with alternatives. Answers provide cautious guidance and emphasise consulting a clinician for personalised advice.
Note: Some responses refer to general principles and may vary with local guidelines or individual medical history.
For personalised information, refer to the official patient information leaflet supplied with the medicine or speak with a pharmacist or doctor.
Consider discussing any specific circumstances or comorbid conditions with a healthcare professional before making changes to treatment.
Choice depends on symptom pattern, prior response to antidepressants, and tolerability. Paxil may be selected when anxiety features are prominent or when there is a concurrent condition that has shown favorable responses to Paxil in experience and guidelines.
Individual differences in side effects and interactions with other medicines also influence the decision.
Direct comparisons between medications should be interpreted cautiously; effectiveness can vary between individuals and conditions. The selection often relies on symptom profile, safety history, and personal experience with the medicine.
Switching may be considered if inadequate symptom control or intolerable side effects occur, or if drug interactions limit therapy. A clinician can outline a tapering plan and a suitable alternative.
Generic paroxetine contains the same active ingredient and is expected to have similar effects when used under proper supervision. Some patients may notice differences in tablet formulation or excipients, which can affect tolerability for some individuals.
The choice depends on how symptoms present and how the patient tolerates each medicine. Paxil may be favored for certain anxiety features or comorbid conditions where prior experience supports its use.
Discontinuation should be performed gradually under medical supervision to minimise withdrawal symptoms and symptom relapse. A plan for tapering and follow-up is typically advised.
Some benefit may be observed within the first weeks, while full therapeutic effect may take longer; individual responses vary and regular follow-up is advised.
Safety during pregnancy requires careful assessment; potential risks must be weighed against the benefits. The clinician may suggest alternatives or adjustments if pregnancy is planned or confirmed.
Weight fluctuations can occur with Paxil; the pattern varies between individuals and may be influenced by appetite and activity levels.
Yes, certain OTC medicines and supplements can interact with Paxil; disclosure to a clinician is essential to prevent adverse effects.
Alcohol can interact with mood and anxiety symptoms and may worsen side effects; moderation or avoidance should be discussed with a clinician.
Use in younger people requires careful clinical judgement; safety and efficacy depend on age and the individual’s medical history, with prescription only in appropriate cases.
Missing a dose should follow a clinician’s guidance; do not double up without advice to avoid potential adverse effects.
Official patient information leaflets, a pharmacist, or a doctor can provide detailed, product-specific information and answers tailored to the individual’s situation.
For comprehensive, product-specific information, refer to the patient information leaflet supplied with Paxil and consult a healthcare professional.
Pharmacists are able to discuss how Paxil interacts with other medicines, and how to manage side effects and monitoring.
Trusted resources from national health services and regulatory bodies may provide additional guidance on indications, safety, and discontinuation planning.
Ongoing follow-up with a clinician is encouraged to review response, tolerability, and any emerging concerns during treatment.
14–21 days. Free from £147.64 .
5–9 days. £22.15
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
